![Susan Abu-Absi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Abu-Absi
Direttore operativo presso
AURA BIOSCIENCES, INC.
Patrimonio netto: 965 803 $ in data 31/08/2026
Profilo
Susan Abu-Absi is Chief Operating Officer at Aura Biosciences, Inc. since 2026.
Formerly, Chief Operating Officer at Be Biopharma, Inc. from 2025 to 2026; Chief Technology & Manufacturing Officer at 2seventy Bio, Inc. from 2022 to 2024; Head-Process & Analytical Development at Genetix Biotherapeutics, Inc.; and Member-Process Sciences Organization at Bayer HealthCare.
Education includes a doctorate from the University of Minnesota and an undergraduate degree from the University of Toledo (Ohio).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,13% | 01/09/2026 | 134.513 ( 0,13% ) | 965 803 $ | 31/08/2026 |
Posizioni attive di Susan Abu-Absi
| Società | Posizione | Inizio |
|---|---|---|
| AURA BIOSCIENCES, INC. | Direttore operativo | 10/08/2026 |
Precedenti posizioni note di Susan Abu-Absi
| Società | Posizione | Fine |
|---|---|---|
Be Biopharma, Inc.
 Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Direttore operativo | 01/06/2026 |
| 2SEVENTY BIO, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2024 |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Corporate Officer/Principal | - |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formazione di Susan Abu-Absi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
33
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toledo (Ohio)
 University of Toledo (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Health Services |
Be Biopharma, Inc.
Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Health Technology |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
